| 000 | 01391 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514052916.0 | ||
| 264 | 0 | _c20030507 | |
| 008 | 200305s 0 0 eng d | ||
| 022 | _a0315-162X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSomers, Emily | |
| 245 | 0 | 0 |
_aAntiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _cDec 2002 |
||
| 300 |
_a2531-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Anticardiolipin _xblood |
| 650 | 0 | 4 |
_aAntiphospholipid Syndrome _xcomplications |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHospitals, University |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLupus Coagulation Inhibitor _xblood |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMaryland _xepidemiology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aVenous Thrombosis _xepidemiology |
| 700 | 1 | _aMagder, Laurence S | |
| 700 | 1 | _aPetri, Michelle | |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 29 _gno. 12 _gp. 2531-6 |
|
| 999 |
_c12270470 _d12270470 |
||